A microbiologist wants to develop a vaccine for prevention of attachment of diarrheagenic E. coli to the specific receptors in the GI tract. All of the following would be appropriate vaccine candidates except:
**Core Concept**
The question revolves around the development of a vaccine targeting the attachment of diarrheagenic E. coli to specific receptors in the gastrointestinal (GI) tract. This involves understanding the pathogenesis of E. coli and its interaction with host cells. The correct answer requires knowledge of the virulence factors and adhesins of E. coli.
**Why the Correct Answer is Right**
The correct answer would be a vaccine candidate that targets the specific receptors in the GI tract. Diarrheagenic E. coli, such as ETEC (Enterotoxigenic E. coli), EPEC (Enteropathogenic E. coli), and EIEC (Enteroinvasive E. coli), attach to the intestinal mucosa using specific adhesins like CFA/I (Colonization Factor Antigen I), CS31A, and EIEC adherence factor. A vaccine targeting these adhesins or the receptors they bind to would prevent attachment and subsequent infection.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it would not target the adhesins or receptors involved in E. coli attachment. For example, a vaccine targeting the E. coli flagellum would not prevent attachment.
**Option B:** This option is incorrect because it would not specifically target the receptors in the GI tract. A vaccine targeting the E. coli capsule would not prevent attachment to the intestinal mucosa.
**Option C:** This option is incorrect because it would not specifically target the adhesins or receptors involved in E. coli attachment. A vaccine targeting the E. coli toxins would not prevent attachment.
**Clinical Pearl / High-Yield Fact**
A key concept to remember is that vaccines targeting the adhesins or receptors of diarrheagenic E. coli can prevent attachment and subsequent infection, making them effective candidates for preventing diarrheal disease.
**Correct Answer:** A.